Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.

Pineoblastomas (PBs) are rare, aggressive pediatric brain tumors of the pineal gland with modest overall survival despite intensive therapy. We sought to define the clinical and molecular spectra of PB to inform new treatment approaches for this orphan cancer. Tumor, blood, and clinical data from 91 patients with PB or supratentorial primitive neuroectodermal tumor (sPNETs/CNS-PNETs), and 2 pineal parenchymal tumors of intermediate differentiation (PPTIDs) were collected from 29 centres in the Rare Brain Tumor Consortium. We used global DNA methylation profiling to define a core group of PB from 72/93 cases, which were delineated into five molecular sub-groups. Copy number, whole exome and targeted sequencing, and miRNA expression analyses were used to evaluate the clinico-pathologic significance of each sub-group. Tumors designated as group 1 and 2 almost exclusively exhibited deleterious homozygous loss-of-function alterations in miRNA biogenesis genes (DICER1, DROSHA, and DGCR8) in 62 and 100% of group 1 and 2 tumors, respectively. Recurrent alterations of the oncogenic MYC-miR-17/92-RB1 pathway were observed in the RB and MYC sub-group, respectively, characterized by RB1 loss with gain of miR-17/92, and recurrent gain or amplification of MYC. PB sub-groups exhibited distinct clinical features: group 1-3 arose in older children (median ages 5.2-14.0 years) and had intermediate to excellent survival (5-year OS of 68.0-100%), while Group RB and MYC PB patients were much younger (median age 1.3-1.4 years) with dismal survival (5-year OS 37.5% and 28.6%, respectively). We identified age < 3 years at diagnosis, metastatic disease, omission of upfront radiation, and chr 16q loss as significant negative prognostic factors across all PBs. Our findings demonstrate that PB exhibits substantial molecular heterogeneity with sub-group-associated clinical phenotypes and survival. In addition to revealing novel biology and therapeutics, molecular sub-grouping of PB can be exploited to reduce treatment intensity for patients with favorable biology tumors

Megatrends and Trends Shaping Supply Chain Innovation

Companies operate in a macro-environment that is changing considerably due to large, transformative global forces namely megatrends and trends. The wave of these megatrends and trends generates new prospects as well as challenges for the future of supply chains. This chapter provides a review of 23 major megatrends and 72 trends identified in multiple dimensions along Political, Economic, Social, Technological, Legal, and Environmental (PESTLE) dimensions. The results are based on a systematic literature review and an experts’ workshop, and can be used to generate future supply chain scenarios

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

Pineoblastomas (PBs) are rare, aggressive pediatric brain tumors of the pineal gland with modest overall survival despite intensive therapy. We sought to define the clinical and molecular spectra of PB to inform new treatment approaches for this orphan cancer. Tumor, blood, and clinical data from 91 patients with PB or supratentorial primitive neuroectodermal tumor (sPNETs/CNS-PNETs), and 2 pineal parenchymal tumors of intermediate differentiation (PPTIDs) were collected from 29 centres in the Rare Brain Tumor Consortium. We used global DNA methylation profiling to define a core group of PB from 72/93 cases, which were delineated into five molecular sub-groups. Copy number, whole exome and targeted sequencing, and miRNA expression analyses were used to evaluate the clinico-pathologic significance of each sub-group. Tumors designated as group 1 and 2 almost exclusively exhibited deleterious homozygous loss-of-function alterations in miRNA biogenesis genes (DICER1, DROSHA, and DGCR8) in 62 and 100% of group 1 and 2 tumors, respectively. Recurrent alterations of the oncogenic MYC-miR-17/92-RB1 pathway were observed in the RB and MYC sub-group, respectively, characterized by RB1 loss with gain of miR-17/92, and recurrent gain or amplification of MYC. PB sub-groups exhibited distinct clinical features: group 1–3 arose in older children (median ages 5.2–14.0 years) and had intermediate to excellent survival (5-year OS of 68.0–100%), while Group RB and MYC PB patients were much younger (median age 1.3–1.4 years) with dismal survival (5-year OS 37.5% and 28.6%, respectively). We identified age

Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study.

BACKGROUND: Embryonal tumours with multi-layered rosettes (ETMRs) are a newly recognised, rare paediatric brain tumour with alterations of the C19MC microRNA locus. Due to varied diagnostic practices and scarce clinical data, disease features and determinants of outcomes for these tumours are poorly defined. We did an integrated clinicopathological and molecular analysis of primary ETMRs to define clinical phenotypes, and to identify prognostic factors of survival and key treatment modalities for this orphan disease. METHODS: Paediatric patients with primary ETMRs and tissue available for analyses were identified from the Rare Brain Tumor Consortium global registry. The institutional histopathological diagnoses were centrally re-reviewed as per the current WHO CNS tumour guidelines, using histopathological and molecular assays. Only patients with complete clinical, treatment, and survival data on Nov 30, 2019, were included in clinicopathological analyses. Among patients who received primary multi-modal curative regimens, event-free survival and overall survival were determined using Cox proportional hazard and log-rank analyses. Univariate and multivariable Cox proportional hazard regression was used to estimate hazard ratios (HRs) with 95% CIs for clinical, molecular, or treatment-related prognostic factors. FINDINGS: 159 patients had a confirmed molecular diagnosis of primary ETMRs (median age at diagnosis 26 months, IQR 18-36) and were included in our clinicopathological analysis. ETMRs were predominantly non-metastatic (94 [73%] of 128 patients), arising from multiple sites; 84 (55%) of 154 were cerebral tumours and 70 (45%) of 154 arose at sites characteristic of other brain tumours. Hallmark C19MC alterations were seen in 144 (91%) of 159 patients; 15 (9%) were ETMR not otherwise specified. In patients treated with curative intent, event-free survival was 57% (95% CI 47-68) at 6 months and 31% (21-42) at 2 years; overall survival was 29% (20-38) at 2 years and 27% (18-37) at 4 years. Overall survival was associated with non-metastatic disease (HR 0·48, 95% CI 0·28-0·80; p=0·0057) and non-brainstem location (0·42 [0·22-0·81]; p=0·013) on univariate analysis, as well as with gross total resection (0·30, 0·16-0·58; p=0·0014), high-dose chemotherapy (0·35, 0·19-0·67; p=0·0020), and radiotherapy (0·21, 0·10-0·41; p<0·0001) on multivariable analysis. 2-year event-free and overall survival was 0% at 2 years in patients treated with conventional chemotherapy without radiotherapy (regardless of surgery extent), and 21% (95% CI 1-41) and 30% (6-54), respectively, in patients treated with high-dose chemotherapy, and gross total resection without radiotherapy. 2-year event-free survival in patients treated with high-dose chemotherapy and radiotherapy was 66% (95% CI 39-93) for patients with gross total resection and 44% (7-81) for patients with sub-total resection. 2-5-year overall survival was 66% (95% CI 33-99, p=0·038) for patients with gross total resection and 67% (36-98, p=0·0020) for patients with sub-total resection. INTERPRETATION: Prompt molecular diagnosis and post-surgical treatment with intensive multi-modal therapy tailored to patient-specific risk features could improve ETMR survival. FUNDING: Canadian Institute of Health Research, Canada Research Chair Awards, Australian Lions Childhood Cancer Research Foundation, Spanish Society of Pediatrics, Consejería de Salud y Familias de la Junta de Andalucía, Miracle Marnie, Phoebe Rose Rocks, Tali's Funds, Garron Cancer Centre, Grace's Walk, Meagan's Hug, Brainchild, Nelina's Hope, and Jean Martel Foundation

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.

Pineoblastomas (PBs) are rare, aggressive pediatric brain tumors of the pineal gland with modest overall survival despite intensive therapy. We sought to define the clinical and molecular spectra of PB to inform new treatment approaches for this orphan cancer. Tumor, blood, and clinical data from 91 patients with PB or supratentorial primitive neuroectodermal tumor (sPNETs/CNS-PNETs), and 2 pineal parenchymal tumors of intermediate differentiation (PPTIDs) were collected from 29 centres in the Rare Brain Tumor Consortium. We used global DNA methylation profiling to define a core group of PB from 72/93 cases, which were delineated into five molecular sub-groups. Copy number, whole exome and targeted sequencing, and miRNA expression analyses were used to evaluate the clinico-pathologic significance of each sub-group. Tumors designated as group 1 and 2 almost exclusively exhibited deleterious homozygous loss-of-function alterations in miRNA biogenesis genes (DICER1, DROSHA, and DGCR8) in 62 and 100% of group 1 and 2 tumors, respectively. Recurrent alterations of the oncogenic MYC-miR-17/92-RB1 pathway were observed in the RB and MYC sub-group, respectively, characterized by RB1 loss with gain of miR-17/92, and recurrent gain or amplification of MYC. PB sub-groups exhibited distinct clinical features: group 1-3 arose in older children (median ages 5.2-14.0 years) and had intermediate to excellent survival (5-year OS of 68.0-100%), while Group RB and MYC PB patients were much younger (median age 1.3-1.4 years) with dismal survival (5-year OS 37.5% and 28.6%, respectively). We identified age < 3 years at diagnosis, metastatic disease, omission of upfront radiation, and chr 16q loss as significant negative prognostic factors across all PBs. Our findings demonstrate that PB exhibits substantial molecular heterogeneity with sub-group-associated clinical phenotypes and survival. In addition to revealing novel biology and therapeutics, molecular sub-grouping of PB can be exploited to reduce treatment intensity for patients with favorable biology tumors

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

© 2019 Elsevier Inc. Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Chr19q13.41 miRNA cluster (C19MC) and enrichment of pluripotency factor LIN28A. Here we investigated C19MC oncogenic mechanisms and discovered a C19MC-LIN28A-MYCN circuit fueled by multiple complex regulatory loops including an MYCN core transcriptional network and super-enhancers resulting from long-range MYCN DNA interactions and C19MC gene fusions. Our data show that this powerful oncogenic circuit, which entraps an early neural lineage network, is potently abrogated by bromodomain inhibitor JQ1, leading to ETMR cell death. Sin-Chan et al. uncover a C19MC-LIN28A-MYCN super-enhancer-dependent oncogenic circuit in embryonal tumors with multilayered rosettes (ETMRs). The circuit entraps an early neural lineage network to sustain embryonic epigenetic programming and is vulnerable to bromodomain inhibition, which promotes ETMR cell death

Global attitudes in the management of acute appendicitis during COVID-19 pandemic: ACIE Appy Study

676sinoneBackground: Surgical strategies are being adapted to face the COVID-19 pandemic. Recommendations on the management of acute appendicitis have been based on expert opinion, but very little evidence is available. This study addressed that dearth with a snapshot of worldwide approaches to appendicitis. Methods: The Association of Italian Surgeons in Europe designed an online survey to assess the current attitude of surgeons globally regarding the management of patients with acute appendicitis during the pandemic. Questions were divided into baseline information, hospital organization and screening, personal protective equipment, management and surgical approach, and patient presentation before versus during the pandemic. Results: Of 744 answers, 709 (from 66 countries) were complete and were included in the analysis. Most hospitals were treating both patients with and those without COVID. There was variation in screening indications and modality used, with chest X-ray plus molecular testing (PCR) being the commonest (19·8 per cent). Conservative management of complicated and uncomplicated appendicitis was used by 6·6 and 2·4 per cent respectively before, but 23·7 and 5·3 per cent, during the pandemic (both P &lt; 0·001). One-third changed their approach from laparoscopic to open surgery owing to the popular (but evidence-lacking) advice from expert groups during the initial phase of the pandemic. No agreement on how to filter surgical smoke plume during laparoscopy was identified. There was an overall reduction in the number of patients admitted with appendicitis and one-third felt that patients who did present had more severe appendicitis than they usually observe. Conclusion: Conservative management of mild appendicitis has been possible during the pandemic. The fact that some surgeons switched to open appendicectomy may reflect the poor guidelines that emanated in the early phase of SARS-CoV-2.noneIelpo B.; Podda M.; Pellino G.; Pata F.; Caruso R.; Gravante G.; Di Saverio S.; Ielpo B.; Podda M.; Pellino G.; Pata F.; Caruso R.; Gravante G.; Di Saverio S.; Gallo G.; Lui R.; Orengia A.; Chowdary A.; Kulkarni A.; Kuvvetli A.; Navarro A.; Pisanu A.; Smith A.; Ibiricu A.C.; Nacion A.J.D.; Alsaleh A.; Alhazmi A.; Elmabri A.; Wani A.; Rencuzogullari A.; Lasarte A.S.; Rubio A.V.; Bavikatte A.; Kumar A.; Jamiri A.-R.; Padilla A.M.A.; Cacurri A.; de San Ildefonso A.; Porcu A.; Sartori A.; Rocca A.; Yanez A.P.; Becaria A.; Solis-Pena A.; Sretenovic A.; Urbistondo A.; Bandin A.; Najar A.; De Luca A.; Boddy A.; Charalabopoulos A.; Tzivanakis A.; Amendola A.; de Velasco A.R.-G.; Yildirim A.C.; Frontali A.; Toure A.O.; Garcia-Granero A.; Roldan A.M.; Larrainzar A.S.; Ratnayake A.S.; Gonzalez-Ganso A.M.; Minaya-Bravo A.M.; Das A.; Bondurri A.; Costanzi A.; Lucchi A.; Mazzari A.; Musig A.; Peloso A.; Piano A.; Police A.; Mihailescu A.; Pouy A.; Romano A.; Iossa A.; Leonetti A.C.; Guariniello A.; Isaac A.; Bovi A.P.D.; Chessa A.; Tromba A.; Martinez A.A.; Brillantino A.; Caira A.; Castaldi A.; Ferronetti A.; Giuliani A.; Prestera A.; la Medina A.R.-D.; Tarasconi A.; Tornambe A.; Picciariello A.; Ioannidis A.; Leppaniemi A.; Khan A.; Rashid A.; Perez-Sanchez A.L.E.; Mittal A.; Mitul A.R.; Mehraj A.; Laharwal A.; Dorisme A.; Marinis A.; Iqbal A.; Moncada A.; Braccio B.; Alkhafaji B.; de Andres Asenjo B.; Martin-Perez B.; Perez B.S.; Creavin B.; Cali B.; Cali B.; Pascotto B.; Stubbs B.; Retes B.Z.; Jovanovic B.; Goh B.K.P.; Sensi B.; Biddau C.; Gazia C.; Vallicelli C.; Fagundes C.A.; Santacruz C.C.; Chirico C.; Diaz C.J.G.; Petrola C.; Rodriguez C.S.; Benitez C.Y.; Dammaro C.; Faro C.L.; Reinke C.; Paez C.D.; Oliva C.; Paranjape C.; Thomas C.; Chia C.F.; Kong C.K.; De Lucia C.; Chao C.O.; Arcudi C.; Guerci C.; Chia C.; Parise C.; Folliero C.; Varela C.; Ferguson D.M.; Camacho D.; Popowich D.; Lima D.S.; Rega D.; Delogu D.; Zigiotto D.; Vinci D.; D'Antonio D.; Parini D.; Merlini D.A.; Zimmerman D.D.E.; Moro-Valdezate D.; Pertile D.; Giusti D.M.; Keller D.S.; Tarik D.; Kalivaci D.; Mazingi D.; Maldonado-Pintado D.G.; Sasia D.; Linardoutsos D.; Osilli D.; Murrone D.; Russello D.; Rodas E.; Roa E.A.A.; Ricciardi E.; Rosso E.; Saladino E.; Flores-Villalba E.; Ajs E.R.; Smith-Singares E.; Baili E.; Kouroumpas E.; Bourmpouteli E.; Douka E.; Martin-Perez E.; Guaitoli E.; Samadov E.; Francone E.; Vaterlini E.; Morales E.; Pena E.; Zhao E.; Andres E.D.P.; Benzoni E.; Erdas E.; Pinotti E.; Colas-Ruiz E.; Aytac E.; Laterza E.; Agastra E.; Foianini E.; Moscoso E.; Laviano E.; Marra E.; Cardamone E.; Licardie E.; Mpaili E.; Pinna E.; Varo E.; Navarro F.M.; Marino F.; Medas F.; Romano F.; Maraska F.; Saliu F.; Madrid F.; Rosa F.; Mastella F.; Gheza F.; Luvisetto F.; Alconchel F.; Vieira F.M.; Pareja F.; Agresta F.; Luna F.; Bonilla F.; Cordera F.; Burdio F.; Mendoza-Moreno F.; Flores F.M.; Aranda F.P.; Taylor F.; Ramos F.L.; Fernandes F.; Tropeano F.P.; Balestra F.; Bianco F.; Ceci F.; Colombo F.; Di Marzo F.; Ferrara F.; Lancellotti F.; Lazzarin F.; Litta F.; Martini F.; Pizza F.; Roscio F.; Virdis F.; Antona F.B.; Ramirez F.C.; Fernandez F.M.; Llinares F.O.; Quezada F.; Schlottmann F.; Quezada F.; Herrera-Almario G.; Massaferro G.; Bislenghi G.; van Ramshorst G.; Gallo G.; Luglio G.; Bointas G.; Kampouroglou G.; Papadopoulos G.; Manrique G.A.; Calini G.; Nastri G.; Formisano G.; Galiffa G.; Palini G.M.; Colucci G.; Pagano G.; Pellino G.; Vanni G.; Pattacini G.C.; Gravante G.; De Paola G.; Lisi G.; Partida G.; Bellanova G.; De Nobili G.; Necchi G.S.; Sinibaldi G.; Tebala G.; Bagaglini G.; Izzo G.; Argenio G.; Brisinda G.; Candilio G.; Di Grezia G.; Esposito G.; Faillace G.; Frazzetta G.; La Gumina G.; Nigri G.; Romeo G.; Amatriain G.C.; Ortega G.; Martin-Martin G.; Stavrou G.A.; Gunadi; Ugon G.A.; Machain G.; Marcucci G.; Martinez-Mier G.; Machain G.M.; Nari G.; Calvo H.; Fathy H.; Hamilto; Ahmed H.; Faraj H.; Nava H.; Macias H.O.; Nikaj H.; Solano H.; Khan H.A.; Alarcon H.S.; Ebied H.; Giani I.; Ateca I.V.; Neri I.; Roman I.A.S.; Fidoshev I.; Rodriguez I.M.; Negoi I.; Ortega I.; Bernescu I.; Russo I.S.; Rodriguez I.V.; Palomares I.; Baltazar I.; Torrejimeno I.J.; Jurado I.M.C.; Reccia I.; Hussain I.; Toledo I.B.; Mora-Guzman I.; Dogaru I.; Romic I.; Balciscueta I.; Kenington J.C.; Sagolsem J.; Jang J.Y.; Olivier J.; Lammel-Lindemann J.; Dziakova J.; Villavicencio J.I.R.; Salinas J.; Parreira J.P.J.G.; Jovanovic; Perez J.R.; Reyes J.A.S.; Luque J.A.M.; Mak J.; Rodriguez J.S.; Kok J.H.H.; Krook J.; Diaz-Elizondo J.A.; Castell J.; Garcia-Flores J.E.; Navalon J.M.J.; Rodrigues J.M.S.; Pereira J.; Gomez J.T.C.; Luque J.B.; del Olmo J.C.M.; Salamea J.C.; Olivier J.F.C.; Laina J.L.B.; Ordonez J.M.; Gutierrez J.; Abba J.; Sofi J.A.; Sherafgan K.; Sahnan K.; Yanaga K.; Beatson K.; Asim L.; Alvarez L.; Siragusa L.; Farber L.; Ong L.; Athanasios L.; Garcia-Bruna L.; De Martino L.; Ferrario L.; Giordano L.; Gordini L.; Pio L.; Ponchietti L.; Moletta L.; Curella L.; Poggi L.; Taglietti L.; Bonavina L.; Conti L.; Goffredi L.; Ruiz L.A.G.; Barrionuevo L.; Fregoso L.E.; Cabrera L.F.; Rodriguez L.G.; Grande L.; Osoria L.G.; Gonzalez L.J.K.; Sanchez-Guillen L.; Tallon-Aguilar L.; Tresierra L.; Giavarini L.; Hasabelnabi M.; Odovic M.; Uemura M.; Khan M.; Artiles-Armas M.; David M.; Di Martino M.; Spampinato M.G.; Ribeiro M.A.F.; Viola M.; Angrisani M.; Calussi M.; Cannistra M.; Catarci M.; Cereda M.; Conte M.; Giordano M.; Pellicciaro M.; Marino M.V.; Vaterlini M.E.; Jimenez M.F.; Lolli M.G.; Bellini M.I.; Lemma M.; Chiarello M.M.; Nicola M.; Arrigo M.; Mejia M.C.; Manrique M.M.; Rodriguez-Lopez M.; Serradilla-Martin M.; Lara M.Z.; Martinez M.; Bagnall M.; Peter M.; Lara M.C.; Gomez M.J.; Paniagua-Garcia-Senorans M.; Gonzalez M.P.; Rutegard M.; Salo M.; Franceschilli M.; Silveri M.; Veroux M.; Pezzulo M.; Nardi M.; Rottoli M.; Tolonen M.; Ciro M.P.; Zuluagua M.; Cannavo M.; Cervellera M.; Iacobone M.; Montuori M.; Podda M.; Dominguez M.G.; Bingol-Kologlu M.; Tahir M.; Lim M.; Wilson M.S.; Wilson M.; Campanelli M.; Bisaccia M.; De Rosa M.; Maruccia M.; Paterno M.; Pisano M.; Torre M.; Trevino M.; Zuolo M.; Hernandez Bartolome M.A.; Farina M.; Pera M.; Calvo M.P.; Sotelo M.; Thway M.M.; Hassan M.; Hassan M.S.E.; Azfar M.; Bouhuwaish M.; Taha M.; Zaieem M.; Korkoman M.; Guraieb M.; Shalaby M.; Raza M.A.; Younis M.U.; Elhadi M.; Ali M.Z.; Quazi N.; Dudi-Venkata N.N.; Alselaim N.; Loria N.; Ramirez N.V.; Than N.W.; Smart N.; Trelles N.; Pinto N.; Allievi N.; Petrucciani N.; Antonacci N.; Cillara N.; Gica N.; Cristiana N.D.; Krystek N.; Falco N.; Pecorelli N.; Tamini N.; Dallas N.A.; Machairas N.; Brito N.; Fieturi N.A.; Ortega N.; Mercado O.A.; Irkorucu O.; Alsherif O.; Valles O.; Ioannidis O.; Palmas O.H.; Palmas O.I.H.; Guadarrama O.S.; Bozbiyik O.; Omelanczuk P.; Ottolino P.; Rodrigues P.; Ruiz P.; Campenni P.; Chiarade P.; Olivares P.P.; Baroffio P.; Panaccio P.; Wintringer P.; Di Fronzo P.; Talento P.; Favoriti P.; Sendino P.; Marsanic P.; Mifsut P.; Andrade P.; Ajawin P.; Abadia-Barno P.; Castaneda P.A.N.; Arevalos P.O.S.; Bellver P.P.; Koh P.S.; Souza P.; Major P.; Bali R.S.; Khattar R.M.; Melo R.B.; Ebrahiminia R.; Azar R.; Murga R.L.; Caruso R.; Pirolo R.; Brady R.; Davies R.J.; Dholakia R.; Rattan R.; Singhal R.; Lim R.; Angelico R.; Isernia R.M.; Tutino R.; Faccincani R.; Peltrini R.; Carrera-Ceron R.; Tejos R.; Kashyap R.; Fajardo R.; Lozito R.; Pareja R.M.; Garbarino S.; Di Saverio S.; Morales-Conde S.; Benli S.; Mansour S.; Flores S.; Suarez S.L.; Ben S.L.; Fuentes S.; Napetti S.; de Guzman S.O.; Awad S.; Weckmann Lujan S.A.; Gentilli S.; Grimaldi S.; Pizarro S.O.; Tayar S.; Nabi S.; Chan S.M.; Junaid S.; Rojas S.; Monetti S.; Garcia S.; Salvans S.; Tenconi S.; Shaw S.; Santoni S.; Parra S.A.; Cardenas S.; Perez-Bertolez S.; Chiappetta S.; Dessureault S.; Delis S.; Bonapasta S.A.; Rausei S.; Scaringi S.; Keswani S.; Ali S.M.; Cetinkunar S.; Fung T.L.D.; Rawashdeh T.; Lopez T.N.; De Campos T.; Duque T.C.; Perra T.; Liakakos T.; Daskalakis T.; Liakakos T.; Barnes T.; Koeter T.; Zalla T.; Gonzalez T.E.; Elosua T.; Campagnaro T.; Brown T.; Luoto T.; Oumar T.A.; Giustizieri U.; Grossi U.; Bracale U.; Rivas U.; Sosa V.; Testa V.; Andriola V.; Tonini V.; Balassone V.; Celentano V.; Progno V.; Raju V.; Carroni V.; Cavallaro V.; Katta V.R.; De Simone V.; Romaguera V.P.; Orozco V.H.G.; Luraschi V.; Rachkov V.; Turrado-L V.; Visag-Castillo V.; Dowling V.; Graham V.; Papagni V.; Vigorita V.; Fonseca V.C.; Carneros V.J.; Bellato V.; Goncalves W.; Powers W.F.; Grigg W.; Bechstein W.O.; Lim Y.B.; Altinel Y.; Golubovic Z.; Balciscueta Z.Ielpo, B.; Podda, M.; Pellino, G.; Pata, F.; Caruso, R.; Gravante, G.; Di Saverio, S.; Ielpo, B.; Podda, M.; Pellino, G.; Pata, F.; Caruso, R.; Gravante, G.; Di Saverio, S.; Gallo, G.; Lui, R.; Orengia, A.; Chowdary, A.; Kulkarni, A.; Kuvvetli, A.; Navarro, A.; Pisanu, A.; Smith, A.; Ibiricu, A. C.; Nacion, A. J. D.; Alsaleh, A.; Alhazmi, A.; Elmabri, A.; Wani, A.; Rencuzogullari, A.; Lasarte, A. S.; Rubio, A. V.; Bavikatte, A.; Kumar, A.; Jamiri, A. -R.; Padilla, A. M. A.; Cacurri, A.; de San Ildefonso, A.; Porcu, A.; Sartori, A.; Rocca, A.; Yanez, A. P.; Becaria, A.; Solis-Pena, A.; Sretenovic, A.; Urbistondo, A.; Bandin, A.; Najar, A.; De Luca, A.; Boddy, A.; Charalabopoulos, A.; Tzivanakis, A.; Amendola, A.; de Velasco, A. R. -G.; Yildirim, A. C.; Frontali, A.; Toure, A. O.; Garcia-Granero, A.; Roldan, A. M.; Larrainzar, A. S.; Ratnayake, A. S.; Gonzalez-Ganso, A. M.; Minaya-Bravo, A. M.; Das, A.; Bondurri, A.; Costanzi, A.; Lucchi, A.; Mazzari, A.; Musig, A.; Peloso, A.; Piano, A.; Police, A.; Mihailescu, A.; Pouy, A.; Romano, A.; Iossa, A.; Leonetti, A. C.; Guariniello, A.; Isaac, A.; Bovi, A. P. D.; Chessa, A.; Tromba, A.; Martinez, A. A.; Brillantino, A.; Caira, A.; Castaldi, A.; Ferronetti, A.; Giuliani, A.; Prestera, A.; la Medina, A. R. -D.; Tarasconi, A.; Tornambe, A.; Picciariello, A.; Ioannidis, A.; Leppaniemi, A.; Khan, A.; Rashid, A.; Perez-Sanchez, A. L. E.; Mittal, A.; Mitul, A. R.; Mehraj, A.; Laharwal, A.; Dorisme, A.; Marinis, A.; Iqbal, A.; Moncada, A.; Braccio, B.; Alkhafaji, B.; de Andres Asenjo, B.; Martin-Perez, B.; Perez, B. S.; Creavin, B.; Cali, B.; Cali, B.; Pascotto, B.; Stubbs, B.; Retes, B. Z.; Jovanovic, B.; Goh, B. K. P.; Sensi, B.; Biddau, C.; Gazia, C.; Vallicelli, C.; Fagundes, C. A.; Santacruz, C. C.; Chirico, C.; Diaz, C. J. G.; Petrola, C.; Rodriguez, C. S.; Benitez, C. Y.; Dammaro, C.; Faro, C. L.; Reinke, C.; Paez, C. D.; Oliva, C.; Paranjape, C.; Thomas, C.; Chia, C. F.; Kong, C. K.; De Lucia, C.; Chao, C. O.; Arcudi, C.; Guerci, C.; Chia, C.; Parise, C.; Folliero, C.; Varela, C.; Ferguson, D. M.; Camacho, D.; Popowich, D.; Lima, D. S.; Rega, D.; Delogu, D.; Zigiotto, D.; Vinci, D.; D'Antonio, D.; Parini, D.; Merlini, D. A.; Zimmerman, D. D. E.; Moro-Valdezate, D.; Pertile, D.; Giusti, D. M.; Keller, D. S.; Tarik, D.; Kalivaci, D.; Mazingi, D.; Maldonado-Pintado, D. G.; Sasia, D.; Linardoutsos, D.; Osilli, D.; Murrone, D.; Russello, D.; Rodas, E.; Roa, E. A. A.; Ricciardi, E.; Rosso, E.; Saladino, E.; Flores-Villalba, E.; Ajs, E. R.; Smith-Singares, E.; Baili, E.; Kouroumpas, E.; Bourmpouteli, E.; Douka, E.; Martin-Perez, E.; Guaitoli, E.; Samadov, E.; Francone, E.; Vaterlini, E.; Morales, E.; Pena, E.; Zhao, E.; Andres, E. D. P.; Benzoni, E.; Erdas, E.; Pinotti, E.; Colas-Ruiz, E.; Aytac, E.; Laterza, E.; Agastra, E.; Foianini, E.; Moscoso, E.; Laviano, E.; Marra, E.; Cardamone, E.; Licardie, E.; Mpaili, E.; Pinna, E.; Varo, E.; Navarro, F. M.; Marino, F.; Medas, F.; Romano, F.; Maraska, F.; Saliu, F.; Madrid, F.; Rosa, F.; Mastella, F.; Gheza, F.; Luvisetto, F.; Alconchel, F.; Vieira, F. M.; Pareja, F.; Agresta, F.; Luna, F.; Bonilla, F.; Cordera, F.; Burdio, F.; Mendoza-Moreno, F.; Flores, F. M.; Aranda, F. P.; Taylor, F.; Ramos, F. L.; Fernandes, F.; Tropeano, F. P.; Balestra, F.; Bianco, F.; Ceci, F.; Colombo, F.; Di Marzo, F.; Ferrara, F.; Lancellotti, F.; Lazzarin, F.; Litta, F.; Martini, F.; Pizza, F.; Roscio, F.; Virdis, F.; Antona, F. B.; Ramirez, F. C.; Fernandez, F. M.; Llinares, F. O.; Quezada, F.; Schlottmann, F.; Quezada, F.; Herrera-Almario, G.; Massaferro, G.; Bislenghi, G.; van Ramshorst, G.; Gallo, G.; Luglio, G.; Bointas, G.; Kampouroglou, G.; Papadopoulos, G.; Manrique, G. A.; Calini, G.; Nastri, G.; Formisano, G.; Galiffa, G.; Palini, G. M.; Colucci, G.; Pagano, G.; Pellino, G.; Vanni, G.; Pattacini, G. C.; Gravante, G.; De Paola, G.; Lisi, G.; Partida, G.; Bellanova, G.; De Nobili, G.; Necchi, G. S.; Sinibaldi, G.; Tebala, G.; Bagaglini, G.; Izzo, G.; Argenio, G.; Brisinda, G.; Candilio, G.; Di Grezia, G.; Esposito, G.; Faillace, G.; Frazzetta, G.; La Gumina, G.; Nigri, G.; Romeo, G.; Amatriain, G. C.; Ortega, G.; Martin-Martin, G.; Stavrou, G. A.; Gunadi, ; Ugon, G. A.; Machain, G.; Marcucci, G.; Martinez-Mier, G.; Machain, G. M.; Nari, G.; Calvo, H.; Fathy, H.; Hamilto, ; Ahmed, H.; Faraj, H.; Nava, H.; Macias, H. O.; Nikaj, H.; Solano, H.; Khan, H. A.; Alarcon, H. S.; Ebied, H.; Giani, I.; Ateca, I. V.; Neri, I.; Roman, I. A. S.; Fidoshev, I.; Rodriguez, I. M.; Negoi, I.; Ortega, I.; Bernescu, I.; Russo, I. S.; Rodriguez, I. V.; Palomares, I.; Baltazar, I.; Torrejimeno, I. J.; Jurado, I. M. C.; Reccia, I.; Hussain, I.; Toledo, I. B.; Mora-Guzman, I.; Dogaru, I.; Romic, I.; Balciscueta, I.; Kenington, J. C.; Sagolsem, J.; Jang, J. Y.; Olivier, J.; Lammel-Lindemann, J.; Dziakova, J.; Villavicencio, J. I. R.; Salinas, J.; Parreira, J. P. J. G.; Jovanovic, ; Perez, J. R.; Reyes, J. A. S.; Luque, J. A. M.; Mak, J.; Rodriguez, J. S.; Kok, J. H. H.; Krook, J.; Diaz-Elizondo, J. A.; Castell, J.; Garcia-Flores, J. E.; Navalon, J. M. J.; Rodrigues, J. M. S.; Pereira, J.; Gomez, J. T. C.; Luque, J. B.; del Olmo, J. C. M.; Salamea, J. C.; Olivier, J. F. C.; Laina, J. L. B.; Ordonez, J. M.; Gutierrez, J.; Abba, J.; Sofi, J. A.; Sherafgan, K.; Sahnan, K.; Yanaga, K.; Beatson, K.; Asim, L.; Alvarez, L.; Siragusa, L.; Farber, L.; Ong, L.; Athanasios, L.; Garcia-Bruna, L.; De Martino, L.; Ferrario, L.; Giordano, L.; Gordini, L.; Pio, L.; Ponchietti, L.; Moletta, L.; Curella, L.; Poggi, L.; Taglietti, L.; Bonavina, L.; Conti, L.; Goffredi, L.; Ruiz, L. A. G.; Barrionuevo, L.; Fregoso, L. E.; Cabrera, L. F.; Rodriguez, L. G.; Grande, L.; Osoria, L. G.; Gonzalez, L. J. K.; Sanchez-Guillen, L.; Tallon-Aguilar, L.; Tresierra, L.; Giavarini, L.; Hasabelnabi, M.; Odovic, M.; Uemura, M.; Khan, M.; Artiles-Armas, M.; David, M.; Di Martino, M.; Spampinato, M. G.; Ribeiro, M. A. F.; Viola, M.; Angrisani, M.; Calussi, M.; Cannistra, M.; Catarci, M.; Cereda, M.; Conte, M.; Giordano, M.; Pellicciaro, M.; Marino, M. V.; Vaterlini, M. E.; Jimenez, M. F.; Lolli, M. G.; Bellini, M. I.; Lemma, M.; Chiarello, M. M.; Nicola, M.; Arrigo, M.; Mejia, M. C.; Manrique, M. M.; Rodriguez-Lopez, M.; Serradilla-Martin, M.; Lara, M. Z.; Martinez, M.; Bagnall, M.; Peter, M.; Lara, M. C.; Gomez, M. J.; Paniagua-Garcia-Senorans, M.; Gonzalez, M. P.; Rutegard, M.; Salo, M.; Franceschilli, M.; Silveri, M.; Veroux, M.; Pezzulo, M.; Nardi, M.; Rottoli, M.; Tolonen, M.; Ciro, M. P.; Zuluagua, M.; Cannavo, M.; Cervellera, M.; Iacobone, M.; Montuori, M.; Podda, M.; Dominguez, M. G.; Bingol-Kologlu, M.; Tahir, M.; Lim, M.; Wilson, M. S.; Wilson, M.; Campanelli, M.; Bisaccia, M.; De Rosa, M.; Maruccia, M.; Paterno, M.; Pisano, M.; Torre, M.; Trevino, M.; Zuolo, M.; Hernandez Bartolome, M. A.; Farina, M.; Pera, M.; Calvo, M. P.; Sotelo, M.; Thway, M. M.; Hassan, M.; Hassan, M. S. E.; Azfar, M.; Bouhuwaish, M.; Taha, M.; Zaieem, M.; Korkoman, M.; Guraieb, M.; Shalaby, M.; Raza, M. A.; Younis, M. U.; Elhadi, M.; Ali, M. Z.; Quazi, N.; Dudi-Venkata, N. N.; Alselaim, N.; Loria, N.; Ramirez, N. V.; Than, N. W.; Smart, N.; Trelles, N.; Pinto, N.; Allievi, N.; Petrucciani, N.; Antonacci, N.; Cillara, N.; Gica, N.; Cristiana, N. D.; Krystek, N.; Falco, N.; Pecorelli, N.; Tamini, N.; Dallas, N. A.; Machairas, N.; Brito, N.; Fieturi, N. A.; Ortega, N.; Mercado, O. A.; Irkorucu, O.; Alsherif, O.; Valles, O.; Ioannidis, O.; Palmas, O. H.; Palmas, O. I. H.; Guadarrama, O. S.; Bozbiyik, O.; Omelanczuk, P.; Ottolino, P.; Rodrigues, P.; Ruiz, P.; Campenni, P.; Chiarade, P.; Olivares, P. P.; Baroffio, P.; Panaccio, P.; Wintringer, P.; Di Fronzo, P.; Talento, P.; Favoriti, P.; Sendino, P.; Marsanic, P.; Mifsut, P.; Andrade, P.; Ajawin, P.; Abadia-Barno, P.; Castaneda, P. A. N.; Arevalos, P. O. S.; Bellver, P. P.; Koh, P. S.; Souza, P.; Major, P.; Bali, R. S.; Khattar, R. M.; Melo, R. B.; Ebrahiminia, R.; Azar, R.; Murga, R. L.; Caruso, R.; Pirolo, R.; Brady, R.; Davies, R. J.; Dholakia, R.; Rattan, R.; Singhal, R.; Lim, R.; Angelico, R.; Isernia, R. M.; Tutino, R.; Faccincani, R.; Peltrini, R.; Carrera-Ceron, R.; Tejos, R.; Kashyap, R.; Fajardo, R.; Lozito, R.; Pareja, R. M.; Garbarino, S.; Di Saverio, S.; Morales-Conde, S.; Benli, S.; Mansour, S.; Flores, S.; Suarez, S. L.; Ben, S. L.; Fuentes, S.; Napetti, S.; de Guzman, S. O.; Awad, S.; Weckmann Lujan, S. A.; Gentilli, S.; Grimaldi, S.; Pizarro, S. O.; Tayar, S.; Nabi, S.; Chan, S. M.; Junaid, S.; Rojas, S.; Monetti, S.; Garcia, S.; Salvans, S.; Tenconi, S.; Shaw, S.; Santoni, S.; Parra, S. A.; Cardenas, S.; Perez-Bertolez, S.; Chiappetta, S.; Dessureault, S.; Delis, S.; Bonapasta, S. A.; Rausei, S.; Scaringi, S.; Keswani, S.; Ali, S. M.; Cetinkunar, S.; Fung, T. L. D.; Rawashdeh, T.; Lopez, T. N.; De Campos, T.; Duque, T. C.; Perra, T.; Liakakos, T.; Daskalakis, T.; Liakakos, T.; Barnes, T.; Koeter, T.; Zalla, T.; Gonzalez, T. E.; Elosua, T.; Campagnaro, T.; Brown, T.; Luoto, T.; Oumar, T. A.; Giustizieri, U.; Grossi, U.; Bracale, U.; Rivas, U.; Sosa, V.; Testa, V.; Andriola, V.; Tonini, V.; Balassone, V.; Celentano, V.; Progno, V.; Raju, V.; Carroni, V.; Cavallaro, V.; Katta, V. R.; De Simone, V.; Romaguera, V. P.; Orozco, V. H. G.; Luraschi, V.; Rachkov, V.; Turrado-L, V.; Visag-Castillo, V.; Dowling, V.; Graham, V.; Papagni, V.; Vigorita, V.; Fonseca, V. C.; Carneros, V. J.; Bellato, V.; Goncalves, W.; Powers, W. F.; Grigg, W.; Bechstein, W. O.; Lim, Y. B.; Altinel, Y.; Golubovic, Z.; Balciscueta, Z